AMAG Pharma (AMAG) Expects FDA Action Letter for Feraheme(TM) Injection Within Next Few Days
Tweet Send to a Friend
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced last night that it has not received an action letter from the U.S. FDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
